SG11202101451QA - Novel heterocyclic amine derivative and pharmaceutical composition comprising same - Google Patents
Novel heterocyclic amine derivative and pharmaceutical composition comprising sameInfo
- Publication number
- SG11202101451QA SG11202101451QA SG11202101451QA SG11202101451QA SG11202101451QA SG 11202101451Q A SG11202101451Q A SG 11202101451QA SG 11202101451Q A SG11202101451Q A SG 11202101451QA SG 11202101451Q A SG11202101451Q A SG 11202101451QA SG 11202101451Q A SG11202101451Q A SG 11202101451QA
- Authority
- SG
- Singapore
- Prior art keywords
- same
- pharmaceutical composition
- amine derivative
- heterocyclic amine
- novel heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20180100359 | 2018-08-27 | ||
| KR1020190104641A KR102328682B1 (en) | 2018-08-27 | 2019-08-26 | Novel heterocyclicamine derivatives and pharmaceutical composition comprising the same |
| PCT/KR2019/010894 WO2020045941A1 (en) | 2018-08-27 | 2019-08-27 | Novel heterocyclic amine derivative and pharmaceutical composition comprising same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202101451QA true SG11202101451QA (en) | 2021-03-30 |
Family
ID=69802542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202101451QA SG11202101451QA (en) | 2018-08-27 | 2019-08-27 | Novel heterocyclic amine derivative and pharmaceutical composition comprising same |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20220064155A1 (en) |
| EP (1) | EP3845530A4 (en) |
| JP (1) | JP7162741B2 (en) |
| KR (1) | KR102328682B1 (en) |
| CN (1) | CN112638910A (en) |
| AU (1) | AU2019331328B2 (en) |
| BR (2) | BR112021003652B1 (en) |
| CA (1) | CA3108856C (en) |
| CL (1) | CL2021000421A1 (en) |
| CO (1) | CO2021001849A2 (en) |
| DO (1) | DOP2021000030A (en) |
| EC (1) | ECSP21011232A (en) |
| MA (1) | MA53507A (en) |
| MX (1) | MX2021002188A (en) |
| PE (1) | PE20210417A1 (en) |
| PH (1) | PH12021550329A1 (en) |
| RU (1) | RU2760184C1 (en) |
| SG (1) | SG11202101451QA (en) |
| TN (1) | TN2021000025A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3999064A4 (en) * | 2019-07-19 | 2023-06-28 | Bridgene Biosciences, Inc. | Inhibitors of tyrosine kinase |
| MX2022010391A (en) * | 2020-02-26 | 2022-09-05 | Daewoong Pharmaceutical Co Ltd | Method for preparation of heterocyclicamine derivatives. |
| KR20210124569A (en) * | 2020-04-03 | 2021-10-15 | 주식회사 하임바이오 | Novel compound for treating cancer and composition comprising the same |
| CN114605404B (en) * | 2022-03-23 | 2024-01-05 | 合肥美诺医药有限公司 | Novel thiazole-containing compound, intermediate and application thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA18829A1 (en) * | 1979-05-18 | 1980-12-31 | Ciba Geigy Ag | PYRIMIDINE DERIVATIVES, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND THEIR THERAPEUTIC USE |
| DE3905763A1 (en) * | 1989-02-24 | 1990-09-06 | Bayer Ag | SULFONYLATED AZINYLIMINOHETEROAZOLES, METHODS AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF AND THEIR USE AS HERBICIDES |
| BR0013899A (en) * | 1999-09-10 | 2003-07-08 | Merck & Co Inc | A compound, pharmaceutical composition, processes for treating or preventing cancer, a disease in which angiogenesis is implicated, retinal vascularization, diabetic retinopathy, age-related macular degeneration, inflammatory diseases, tyrosine-dependent disease or conditions. kinase, bone-associated pathologies, and processes for producing a pharmaceutical composition, and for reducing or preventing tissue damage following a cerebral ischemic event |
| AU2001292670A1 (en) * | 2000-09-15 | 2002-03-26 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| US20020137755A1 (en) * | 2000-12-04 | 2002-09-26 | Bilodeau Mark T. | Tyrosine kinase inhibitors |
| WO2006124874A2 (en) * | 2005-05-12 | 2006-11-23 | Kalypsys, Inc. | Inhibitors of b-raf kinase |
| US7855194B2 (en) * | 2006-03-27 | 2010-12-21 | Hoffmann-La Roche Inc. | Pyrimidine, quinazoline, pteridine and triazine derivatives |
| US8002915B2 (en) * | 2006-09-30 | 2011-08-23 | Tk Holdings, Inc. | Gas generant compositions |
| CN102482277B (en) * | 2009-05-05 | 2017-09-19 | 达纳-法伯癌症研究所有限公司 | Epidermal growth factor receptor inhibitor and the method for treating obstacle |
| CA2764823A1 (en) * | 2009-06-08 | 2010-12-16 | California Capital Equity, Llc | Triazine derivatives and their therapeutical applications |
| RU2012114902A (en) * | 2009-09-16 | 2013-10-27 | Авила Терапьютикс, Инк. | CONJUGATES AND PROTEINKINASE INHIBITORS |
| WO2012035055A1 (en) * | 2010-09-17 | 2012-03-22 | Glaxo Group Limited | Novel compounds |
| KR101682417B1 (en) * | 2011-02-25 | 2016-12-06 | 주식회사유한양행 | Diaminopyrimidine derivatives and processes for the preparation thereof |
| UA111756C2 (en) * | 2011-11-03 | 2016-06-10 | Ф. Хоффманн-Ля Рош Аг | HETEROARYLPYRIDONE AND AZAPIRIDONE COMPOUNDS AS BRUTON TYROSINKINASE INHIBITORS |
| KR101893112B1 (en) * | 2012-01-06 | 2018-08-30 | 아지오스 파마슈티컬스 아이엔씨. | Therapeutically active compounds and their methods of use |
| JP2015526520A (en) * | 2012-08-31 | 2015-09-10 | プリンシピア バイオファーマ インコーポレイテッド | Benzimidazole derivatives as ITK inhibitors |
| WO2014048065A1 (en) * | 2012-09-28 | 2014-04-03 | Merck Sharp & Dohme Corp. | Triazolyl derivatives as syk inhibitors |
| CN105164114B (en) * | 2013-05-01 | 2018-03-23 | 豪夫迈·罗氏有限公司 | The miazines and their purposes of the Heterocyclylalkyl substitution of C connections |
| WO2015025197A1 (en) * | 2013-08-22 | 2015-02-26 | Jubilant Biosys Limited | Substituted pyrimidine compounds, compositions and medicinal applications thereof |
| PT3060550T (en) * | 2013-10-21 | 2019-08-27 | Merck Patent Gmbh | Heteroaryl compounds as btk inhibitors and uses thereof |
| GEP20196983B (en) * | 2014-01-14 | 2019-06-25 | Millennium Pharm Inc | Heteroaryls and uses thereof |
| WO2016001341A1 (en) * | 2014-07-03 | 2016-01-07 | F. Hoffmann-La Roche Ag | Sulfonylaminopyridine compounds, compositions and methods of use |
| CA2965178C (en) * | 2014-10-22 | 2023-09-26 | Dana-Farber Cancer Institute, Inc. | Thiazolyl-containing compounds for treating proliferative diseases |
| CN107922354B (en) * | 2015-05-07 | 2021-05-25 | 苏州韬略生物科技有限公司 | Heterocyclic compounds as IDH2 inhibitors |
-
2019
- 2019-08-26 KR KR1020190104641A patent/KR102328682B1/en active IP Right Grant
- 2019-08-27 TN TNP/2021/000025A patent/TN2021000025A1/en unknown
- 2019-08-27 BR BR112021003652-0A patent/BR112021003652B1/en active IP Right Grant
- 2019-08-27 SG SG11202101451QA patent/SG11202101451QA/en unknown
- 2019-08-27 CA CA3108856A patent/CA3108856C/en active Active
- 2019-08-27 US US17/269,325 patent/US20220064155A1/en active Pending
- 2019-08-27 MA MA053507A patent/MA53507A/en unknown
- 2019-08-27 EP EP19855534.4A patent/EP3845530A4/en active Pending
- 2019-08-27 AU AU2019331328A patent/AU2019331328B2/en active Active
- 2019-08-27 MX MX2021002188A patent/MX2021002188A/en unknown
- 2019-08-27 PE PE2021000205A patent/PE20210417A1/en unknown
- 2019-08-27 CN CN201980056437.8A patent/CN112638910A/en active Pending
- 2019-08-27 RU RU2021107433A patent/RU2760184C1/en active
- 2019-08-27 BR BR122022001938-2A patent/BR122022001938B1/en active IP Right Grant
- 2019-08-27 JP JP2021534102A patent/JP7162741B2/en active Active
-
2021
- 2021-02-16 CO CONC2021/0001849A patent/CO2021001849A2/en unknown
- 2021-02-16 PH PH12021550329A patent/PH12021550329A1/en unknown
- 2021-02-17 DO DO2021000030A patent/DOP2021000030A/en unknown
- 2021-02-18 EC ECSENADI202111232A patent/ECSP21011232A/en unknown
- 2021-02-18 CL CL2021000421A patent/CL2021000421A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO2021001849A2 (en) | 2021-02-26 |
| CL2021000421A1 (en) | 2021-07-23 |
| AU2019331328B2 (en) | 2022-03-17 |
| EP3845530A1 (en) | 2021-07-07 |
| PE20210417A1 (en) | 2021-03-04 |
| CN112638910A (en) | 2021-04-09 |
| EP3845530A4 (en) | 2022-04-27 |
| RU2760184C1 (en) | 2021-11-22 |
| CA3108856C (en) | 2023-05-16 |
| BR122022001938B1 (en) | 2022-04-19 |
| JP2021534256A (en) | 2021-12-09 |
| ECSP21011232A (en) | 2021-03-31 |
| MX2021002188A (en) | 2021-05-14 |
| US20220064155A1 (en) | 2022-03-03 |
| MA53507A (en) | 2022-04-27 |
| DOP2021000030A (en) | 2021-05-31 |
| KR20200024111A (en) | 2020-03-06 |
| CA3108856A1 (en) | 2020-03-05 |
| JP7162741B2 (en) | 2022-10-28 |
| TN2021000025A1 (en) | 2022-10-03 |
| AU2019331328A1 (en) | 2021-03-11 |
| PH12021550329A1 (en) | 2021-10-04 |
| BR112021003652A2 (en) | 2021-05-18 |
| BR112021003652B1 (en) | 2022-04-26 |
| KR102328682B1 (en) | 2021-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL266611B (en) | Substituted n-(3-fluoropropyl)-pyrrolidine compounds and pharmaceutical composition thereof | |
| ZA202007143B (en) | Pyridone derivative, composition thereof and application thereof as anti-influenza drug | |
| GB201910135D0 (en) | Heterocyclic urea compound and pharmaceutical composition and application thereof | |
| SG11202101451QA (en) | Novel heterocyclic amine derivative and pharmaceutical composition comprising same | |
| ZA202106304B (en) | Heterocyclic compound and use thereof | |
| PL3287443T3 (en) | 6-membered heterocyclic derivative and pharmaceutical composition comprising same | |
| PT3580208T (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| IL253538A0 (en) | Heterocyclic compound and pharmaceutical composition comprising same | |
| EP3750890A4 (en) | Alkoxybenzo-five-membered (six-membered) heterocyclic amine compound and pharmaceutical use thereof | |
| EP3409660A4 (en) | Cyclic amine derivative and pharmaceutical use thereof | |
| EP3476846A4 (en) | Novel heterocyclic derivative compound and use thereof | |
| ZA201908107B (en) | Heterocyclic compound and composition containing same | |
| IL287026A (en) | Heterocyclic compounds and uses thereof | |
| SG11202010985TA (en) | Heterocyclic derivatives and use thereof | |
| HK1246785A1 (en) | Nitrogenous heterocyclic amide derivative, preparation method thereof, and pharmaceutical application | |
| EP3697419A4 (en) | Amine-substituted heterocyclic compounds as ehmt2 inhibitors and derivatives thereof | |
| IL276912A (en) | Heterocyclic compound and use thereof | |
| GB2590189B (en) | Lycorine derivative, and pharmaceutical composition and use thereof | |
| SG11202002422WA (en) | Novel phenylpyridine derivative and pharmaceutical composition comprising the same | |
| IL279441A (en) | N-substituted tetrahydrothienopyridine derivatives and uses thereof | |
| IL281324A (en) | Novel heteroaromatic amide derivative and medicine containing same | |
| IL276783A (en) | Novel compound and pharmaceutical composition compirisng same | |
| IL279877A (en) | Ivosidenib forms and pharmaceutical compositions | |
| ZA202000959B (en) | Adamantylmethylamine derivative and use thereof as pharmaceutical | |
| TWI839382B (en) | Novel heterocyclic aromatic amide derivatives and medicines containing the same |